Uni-Bio Science Group (HKSE:00690) EBIT : HK$104.7 Mil (TTM As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group EBIT?

Uni-Bio Science Group's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$71.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$104.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Uni-Bio Science Group's annualized ROC % for the quarter that ended in Jun. 2024 was 48.97%. Uni-Bio Science Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 117.93%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Uni-Bio Science Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 30.90%.

Uni-Bio Science Group EBIT Historical Data

The historical data trend for Uni-Bio Science Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uni-Bio Science Group EBIT Chart

Uni-Bio Science Group Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

5.89

-70.87

-19.54

43.66

76.68

Uni-Bio Science Group Semi-Annual Data
	Sep14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial															15.46	28.21	43.82	32.86	71.81

Competitive Comparison of Uni-Bio Science Group's EBIT

For the Biotechnology subindustry, Uni-Bio Science Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Uni-Bio Science Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Uni-Bio Science Group's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Uni-Bio Science Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$104.7 Mil.

Uni-Bio Science Group (HKSE:00690) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Uni-Bio Science Group's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	137.892 * ( 1 - 5.82% )	/	( (254.55	+	275.867)	/ 2 )
=	129.8666856	/	265.2085
=	48.97 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	409.992	-	32.136	-	( 129.236	-	max(0, 114.79	-	238.096	+	129.236	))
=	254.55

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	487.086	-	46.298	-	( 164.921	-	max(0, 118.316	-	296.352	+	164.921	))
=	275.867

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Uni-Bio Science Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	143.616	/	( ( (119.554 + max(-24.361, 0))	+	(123.745 + max(0.27099999999999, 0)) )	/	2 )
=	143.616	/	( ( 119.554	+	124.016 )	/	2 )
=	143.616	/	121.785
=	117.93 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(35.34	+	36.392	+	0)	-	(32.136	+	0	+	63.957)
=	-24.361

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(42.873	+	40.156	+	0)	-	(46.298	+	0	+	36.46)
=	0.27099999999999

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Uni-Bio Science Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	104.669	/	338.769
	=	30.90 %

Uni-Bio Science Group EBIT Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Uni-Bio Science Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG

Website

https://www.uni-bioscience.com

Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.

Executives

Automatic Result Limited
Mjkpc Holdings Limited	2201 Interest of corporation controlled by you
Leung Kingsley
Yau Kwok Wing Tony	2201 Interest of corporation controlled by you
Century Ally Ventures Limited	2201 Interest of corporation controlled by you
Fih (bvi) Limited	2201 Interest of corporation controlled by you
Futec Investments Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd	2201 Interest of corporation controlled by you
Mjkpc Holdings Limited
Petite Arbre Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Xjg Capital Management Limited	2201 Interest of corporation controlled by you
Lau Kan Sum	2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited	2301 Trustee

Uni-Bio Science Group Headlines

No Headlines